Ensysce Biosciences Valuation
| ENSC Stock | USD 3.45 0.11 3.09% |
At this time, the firm appears to be overvalued. Ensysce Biosciences shows a prevailing Real Value of $3.24 per share. The current price of the firm is $3.45. Our model computes the value of Ensysce Biosciences from reviewing the firm fundamentals such as Profit Margin of (1.53) %, shares outstanding of 1.41 M, and Current Valuation of 2.01 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ensysce Biosciences' valuation include:
Overvalued
Today
Please note that Ensysce Biosciences' price fluctuation is very risky at this time. Calculation of the real value of Ensysce Biosciences is based on 3 months time horizon. Increasing Ensysce Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ensysce Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ensysce Stock. However, Ensysce Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.45 | Real 3.24 | Target 13.72 | Hype 3.56 | Naive 3.1 |
The real value of Ensysce Stock, also known as its intrinsic value, is the underlying worth of Ensysce Biosciences Company, which is reflected in its stock price. It is based on Ensysce Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ensysce Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ensysce Biosciences helps investors to forecast how Ensysce stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ensysce Biosciences more accurately as focusing exclusively on Ensysce Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ensysce Biosciences' intrinsic value based on its ongoing forecasts of Ensysce Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ensysce Biosciences' closest peers. If more than one evaluation category is relevant for Ensysce Biosciences we suggest using both methods to arrive at a better estimate.
Ensysce Biosciences Cash |
|
Ensysce Valuation Trend
Comparing Ensysce Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Ensysce Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Ensysce Biosciences Total Value Analysis
Ensysce Biosciences is currently projected to have valuation of 2.01 M with market capitalization of 5 M, debt of 301.66 B, and cash on hands of 3.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ensysce Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.01 M | 5 M | 301.66 B | 3.15 M |
Ensysce Biosciences Asset Utilization
One of the ways to look at asset utilization of Ensysce is to check how much profit was generated for every dollar of assets it reports. Ensysce Biosciences shows a negative utilization of assets of -1.01 percent, losing $0.0101 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Ensysce Biosciences shows how discouraging it operates for each dollar spent on its assets.Ensysce Biosciences Ownership Allocation
Roughly 89.15 percent of Ensysce Biosciences outstanding shares are held by general public with 0.83 (percent) owned by insiders and only 10.02 % by other corporate entities.Ensysce Biosciences Profitability Analysis
Net Loss for the year was (7.99 T) with loss before overhead, payroll, taxes, and interest of (2.01 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ensysce Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ensysce Biosciences and how it compares across the competition.
About Ensysce Biosciences Valuation
The stock valuation mechanism determines Ensysce Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Ensysce Biosciences. We calculate exposure to Ensysce Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ensysce Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4.8 M | -5.1 M | |
| Pretax Profit Margin | (5.48) | (5.75) | |
| Operating Profit Margin | (5.53) | (5.80) | |
| Net Loss | (5.47) | (5.75) | |
| Gross Profit Margin | (2.76) | (2.90) |
Ensysce Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.7 M |
Ensysce Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Ensysce Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ensysce we look at many different elements of the entity such as Ensysce's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ensysce Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ensysce Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ensysce Biosciences' worth.Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |